Tactile Medical to Present at Upcoming Investor Conferences in June
Tactile Medical (NASDAQ: TCMD), a medical technology company focused on therapies for chronic disorders, has announced its participation in two major investor conferences in June 2025. The company will present at the William Blair 45th Annual Growth Stock Conference in Chicago on June 3 at 3:20 p.m. CST, followed by a presentation at the Jefferies Global Healthcare Conference in New York on June 4 at 2:35 p.m. EST.
Live audio webcasts of both presentations will be available on the company's investor relations website under the "Events & Webcasts" section, with replay options available after the conferences. Tactile Medical specializes in at-home therapies for conditions including lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease.
Tactile Medical (NASDAQ: TCMD), un'azienda di tecnologia medica specializzata in terapie per disturbi cronici, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel giugno 2025. La società presenterà al William Blair 45th Annual Growth Stock Conference a Chicago il 3 giugno alle 15:20 CST, seguita da una presentazione al Jefferies Global Healthcare Conference a New York il 4 giugno alle 14:35 EST.
Le presentazioni saranno trasmesse in diretta audio sul sito web delle relazioni con gli investitori della società, nella sezione "Events & Webcasts", con la possibilità di rivedere le registrazioni dopo le conferenze. Tactile Medical è specializzata in terapie domiciliari per condizioni quali linfedema, lipedema, insufficienza venosa cronica e malattie polmonari croniche.
Tactile Medical (NASDAQ: TCMD), una empresa de tecnología médica enfocada en terapias para trastornos crónicos, ha anunciado su participación en dos importantes conferencias para inversores en junio de 2025. La compañía presentará en la William Blair 45th Annual Growth Stock Conference en Chicago el 3 de junio a las 3:20 p.m. CST, seguida de una presentación en la Jefferies Global Healthcare Conference en Nueva York el 4 de junio a las 2:35 p.m. EST.
Las presentaciones en audio en vivo estarán disponibles en el sitio web de relaciones con inversores de la compañía, en la sección "Events & Webcasts", con opciones de repetición después de las conferencias. Tactile Medical se especializa en terapias domiciliarias para condiciones como linfedema, lipedema, insuficiencia venosa crónica y enfermedades pulmonares crónicas.
Tactile Medical (NASDAQ: TCMD)는 만성 질환 치료에 중점을 둔 의료 기술 회사로, 2025년 6월에 열리는 두 주요 투자자 컨퍼런스에 참여할 예정임을 발표했습니다. 회사는 6월 3일 오후 3시 20분 CST에 시카고에서 열리는 William Blair 45th Annual Growth Stock Conference에서 발표하며, 이어서 6월 4일 오후 2시 35분 EST에 뉴욕에서 열리는 Jefferies Global Healthcare Conference에서 발표할 예정입니다.
두 발표 모두 회사 투자자 관계 웹사이트의 "Events & Webcasts" 섹션에서 라이브 오디오 웹캐스트로 제공되며, 컨퍼런스 종료 후 다시보기 옵션도 제공됩니다. Tactile Medical은 림프부종, 지방부종, 만성 정맥 부전, 만성 폐질환 등 가정 내 치료에 특화되어 있습니다.
Tactile Medical (NASDAQ: TCMD), une entreprise de technologie médicale spécialisée dans les thérapies pour les troubles chroniques, a annoncé sa participation à deux grandes conférences d'investisseurs en juin 2025. La société présentera au William Blair 45th Annual Growth Stock Conference à Chicago le 3 juin à 15h20 CST, suivie d'une présentation au Jefferies Global Healthcare Conference à New York le 4 juin à 14h35 EST.
Les webcasts audio en direct des deux présentations seront disponibles sur le site web des relations investisseurs de la société, dans la section "Events & Webcasts", avec des options de replay après les conférences. Tactile Medical se spécialise dans les thérapies à domicile pour des affections telles que le lymphœdème, le lipœdème, l'insuffisance veineuse chronique et les maladies pulmonaires chroniques.
Tactile Medical (NASDAQ: TCMD), ein Medizintechnikunternehmen, das sich auf Therapien für chronische Erkrankungen spezialisiert hat, hat seine Teilnahme an zwei großen Investorenkonferenzen im Juni 2025 angekündigt. Das Unternehmen wird am William Blair 45th Annual Growth Stock Conference in Chicago am 3. Juni um 15:20 Uhr CST präsentieren, gefolgt von einer Präsentation auf der Jefferies Global Healthcare Conference in New York am 4. Juni um 14:35 Uhr EST.
Live-Audio-Webcasts beider Präsentationen werden auf der Investor-Relations-Website des Unternehmens unter der Rubrik "Events & Webcasts" verfügbar sein, mit Wiedergabeoptionen nach den Konferenzen. Tactile Medical ist auf häusliche Therapien für Erkrankungen wie Lymphödem, Lipödem, chronische Venenschwäche und chronische Lungenerkrankungen spezialisiert.
- None.
- None.
MINNEAPOLIS, May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will be participating in two upcoming investor conferences. Tactile Medical is scheduled to present at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 3:20 p.m. CST and at the Jefferies Global Healthcare Conference in New York on Wednesday, June 4, 2025, at 2:35 p.m. EST.
Event: William Blair 45th Annual Growth Stock Conference
Date: Tuesday, June 3, 2025
Time: 3:20 p.m. CST
Event: Jefferies Global Healthcare Conference
Date: Wednesday, June 4, 2025
Time: 2:35 p.m. EST
A live audio webcast of the presentations will be accessible under the “Events & Webcasts” section of the Company's investor relations website at http://investors.tactilemedical.com. An archive of the webcasts will be available for replay following the conference.
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
FAQ
When is Tactile Medical (TCMD) presenting at the William Blair Conference in June 2025?
What time is Tactile Medical's presentation at the Jefferies Global Healthcare Conference 2025?
Where can investors watch Tactile Medical's (TCMD) conference presentations?
What medical conditions does Tactile Medical (TCMD) treat?
